Polyphenols in Metabolic Diseases

Comprendre polyphenols metabolic diseasesPolyphenols metabolic diseases : molecules. 2022 Sep 23;27(19):6280. doi: 10.3390/molecules27196280. ABSTRACT Polyphenols (PPs) are a large group of phytochemicals containing phenolic rings with two or more hydroxyl groups. They possess powerful antioxidant properties, multiple therapeutic effects, and possible health benefits in vivo and in vitro, as well as reported clinical studies. Considering their free-radical scavenging and anti-inflammatory properties, these substances can be used to treat different kinds of conditions associated with metabolic disorders. Many Ce que disent les donnéessymptoms of metabolic syndrome (MtS), including obesity, dyslipidemia, atherosclerosis, elevated blood sugar, accelerating aging, liver intoxication, hypertension, as well as cancer and neurodegenerative disorders, are substantially relieved by dietary PPs. The present study explores the bioprotective properties and associated underlying mechanisms of PPs. A detailed understanding of these natural compounds will open up new opportunities for producing unique natural PP-rich dietary and medicinal plans, ultimately affirming their health benefits. PMID:36234817 | PMC:PMC9570923 | DOI:10.3390/molecules27196280Points clés sur polyphenols metabolic diseasesL'article « Polyphenols in Metabolic Diseases » aborde un sujet recherché par les professionnels de santé. Outre la lecture ci-dessus, il est utile de replacer polyphenols metabolic diseases dans le contexte global de l'alimentation thérapeutique : individualiser les apports, vérifier les interactions avec les traitements et documenter les objectifs avec le patient.Pour approfondir, croisez ces informations avec les recommandations HAS, les avis de la ANSES et les données cliniques récentes publiées sur le sujet.